SCHEMBL8780739

SCHEMBL8780739

c1cc(-n2c3ccccc3c3ccccc32)c2cc3c(ccc4c(-n5c6ccccc6c6ccccc65)cccc43)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
CYP1A2 P05177 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 2/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ACHE P22303 2/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
AHR P35869 1/20 0.41
CYP1B1 Q16678 2/20 0.39
HIF1A Q16665 1/20 0.39
HPRT1 P00492 3/20 0.38
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GSR P00390 1/20 0.37
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8780546 0.95 TDP1 (0.51) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL8780742 0.92 ALDH1A1 (0.51) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL8780525 0.86 ALDH1A1 (0.57) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL28797770 0.86 TDP1 (0.66) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL28744945 0.86 GSR (0.46) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL20227707 0.83 TDP1 (0.63) TDP1CYP1A2ALDH1A1HSD17B10CYP2C9
SCHEMBL18566830 0.82 TDP1 (0.41) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL14557135 0.80 ALDH1A1 (0.55) TDP1CYP1A2ALDH1A1HPGDCYP2C19
SCHEMBL3326446 0.80 ALDH1A1 (0.40) TDP1CYP1A2ALDH1A1HSD17B10HPGD
SCHEMBL29827886 0.78 CYP1A2 (0.49) TDP1CYP1A2ALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499459-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-22 US disclosed
US-9499459-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-22 US disclosed
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-24 US disclosed
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-24 US disclosed
WO-2011012212-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2011-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MYB, L1CAM, SLC25A21 TDP1 2212/4885CYP1A2 820/4885ALDH1A1 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.